

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.70568087 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.70568087 |
| 3 | cellular potassium ion homeostasis (GO:0030007) | 5.60739997 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.37210369 |
| 5 | sodium ion export (GO:0071436) | 5.05040704 |
| 6 | vocalization behavior (GO:0071625) | 4.73457975 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.71452001 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.68231241 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.62927355 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.50302989 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.43251893 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.41912146 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.40815669 |
| 14 | potassium ion homeostasis (GO:0055075) | 4.19319118 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.14683164 |
| 16 | protein localization to synapse (GO:0035418) | 4.13743865 |
| 17 | cerebellar granule cell differentiation (GO:0021707) | 4.12316171 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09494356 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.05581713 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.03659627 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.00321267 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.96001163 |
| 23 | presynaptic membrane organization (GO:0097090) | 3.94144586 |
| 24 | presynaptic membrane assembly (GO:0097105) | 3.88445391 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 3.86522149 |
| 26 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.83925536 |
| 27 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.75900434 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 3.75404255 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75380277 |
| 30 | transmission of nerve impulse (GO:0019226) | 3.74799216 |
| 31 | potassium ion import (GO:0010107) | 3.73476459 |
| 32 | neuron recognition (GO:0008038) | 3.70952406 |
| 33 | detection of calcium ion (GO:0005513) | 3.70312357 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69426923 |
| 35 | cellular sodium ion homeostasis (GO:0006883) | 3.68718914 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 3.68294487 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 3.68147335 |
| 38 | cerebellar Purkinje cell layer development (GO:0021680) | 3.65626084 |
| 39 | glutamate secretion (GO:0014047) | 3.65135310 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.63684099 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63545653 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.61709717 |
| 43 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.61653592 |
| 44 | locomotory exploration behavior (GO:0035641) | 3.60305312 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.58363925 |
| 46 | negative regulation of neurotransmitter transport (GO:0051589) | 3.58352880 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.58322616 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 3.57576198 |
| 49 | synaptic transmission, dopaminergic (GO:0001963) | 3.55331548 |
| 50 | cell communication by electrical coupling (GO:0010644) | 3.51594010 |
| 51 | mechanosensory behavior (GO:0007638) | 3.50632145 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48759024 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48702868 |
| 54 | prepulse inhibition (GO:0060134) | 3.45769662 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45598578 |
| 56 | auditory behavior (GO:0031223) | 3.43343928 |
| 57 | behavioral response to cocaine (GO:0048148) | 3.41864201 |
| 58 | regulation of glutamate secretion (GO:0014048) | 3.38313561 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36677341 |
| 60 | regulation of synaptic vesicle transport (GO:1902803) | 3.35786006 |
| 61 | myelin maintenance (GO:0043217) | 3.35029502 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.34163546 |
| 63 | proline transport (GO:0015824) | 3.32563258 |
| 64 | adult walking behavior (GO:0007628) | 3.31545728 |
| 65 | positive regulation of synapse maturation (GO:0090129) | 3.30621923 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.27830795 |
| 67 | neurotransmitter transport (GO:0006836) | 3.27214438 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 3.25766384 |
| 69 | amino acid import (GO:0043090) | 3.25563448 |
| 70 | regulation of vesicle fusion (GO:0031338) | 3.25472341 |
| 71 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.25383750 |
| 72 | fatty acid elongation (GO:0030497) | 3.25274864 |
| 73 | mating behavior (GO:0007617) | 3.24471431 |
| 74 | positive regulation of membrane potential (GO:0045838) | 3.22883056 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 3.22232614 |
| 76 | response to histamine (GO:0034776) | 3.21618571 |
| 77 | membrane depolarization during action potential (GO:0086010) | 3.21489750 |
| 78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21309154 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 3.20866796 |
| 80 | glycine transport (GO:0015816) | 3.20079813 |
| 81 | long-term memory (GO:0007616) | 3.19721836 |
| 82 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17560287 |
| 83 | neuronal ion channel clustering (GO:0045161) | 3.17175630 |
| 84 | startle response (GO:0001964) | 3.17112965 |
| 85 | axonal fasciculation (GO:0007413) | 3.16820290 |
| 86 | exploration behavior (GO:0035640) | 3.13637349 |
| 87 | response to auditory stimulus (GO:0010996) | 3.09709016 |
| 88 | long-term synaptic potentiation (GO:0060291) | 3.09160868 |
| 89 | regulation of neurotransmitter uptake (GO:0051580) | 3.08910751 |
| 90 | regulation of ARF protein signal transduction (GO:0032012) | 3.08585225 |
| 91 | neurofilament cytoskeleton organization (GO:0060052) | 3.07147449 |
| 92 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05323939 |
| 93 | striatum development (GO:0021756) | 3.05231606 |
| 94 | acidic amino acid transport (GO:0015800) | 3.04614174 |
| 95 | positive regulation of dendritic spine development (GO:0060999) | 3.04570411 |
| 96 | neuromuscular process controlling posture (GO:0050884) | 3.03573651 |
| 97 | chemosensory behavior (GO:0007635) | 3.03479205 |
| 98 | neurotransmitter uptake (GO:0001504) | 3.03162673 |
| 99 | regulation of neurotransmitter levels (GO:0001505) | 3.02694180 |
| 100 | synapse assembly (GO:0007416) | 3.01906710 |
| 101 | postsynaptic membrane organization (GO:0001941) | 3.01528883 |
| 102 | L-amino acid import (GO:0043092) | 3.01055380 |
| 103 | synaptic transmission (GO:0007268) | 2.99234609 |
| 104 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.95690952 |
| 105 | regulation of synaptic plasticity (GO:0048167) | 2.94572963 |
| 106 | regulation of catecholamine metabolic process (GO:0042069) | 2.94281887 |
| 107 | regulation of dopamine metabolic process (GO:0042053) | 2.94281887 |
| 108 | cell communication involved in cardiac conduction (GO:0086065) | 2.94210353 |
| 109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93931983 |
| 110 | C4-dicarboxylate transport (GO:0015740) | 2.93676490 |
| 111 | positive regulation of synapse assembly (GO:0051965) | 2.92851886 |
| 112 | membrane depolarization (GO:0051899) | 2.92630387 |
| 113 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.88863131 |
| 114 | learning (GO:0007612) | 2.88642348 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88441167 |
| 116 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.87814308 |
| 117 | regulation of neurotransmitter transport (GO:0051588) | 2.86657268 |
| 118 | synaptic vesicle endocytosis (GO:0048488) | 2.85338494 |
| 119 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.85324837 |
| 120 | cell differentiation in hindbrain (GO:0021533) | 2.84750388 |
| 121 | substantia nigra development (GO:0021762) | 2.84362302 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.84358621 |
| 123 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.84088114 |
| 124 | regulation of protein kinase A signaling (GO:0010738) | 2.83353903 |
| 125 | glycosphingolipid biosynthetic process (GO:0006688) | 2.82815795 |
| 126 | negative regulation of amino acid transport (GO:0051956) | 2.80186436 |
| 127 | regulation of dendritic spine development (GO:0060998) | 2.79063476 |
| 128 | response to methylmercury (GO:0051597) | 2.79056108 |
| 129 | neuromuscular process controlling balance (GO:0050885) | 2.77887185 |
| 130 | myelination (GO:0042552) | 2.77866394 |
| 131 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.77539720 |
| 132 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.77324194 |
| 133 | response to amphetamine (GO:0001975) | 2.76337778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.50394538 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85818717 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08465351 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98660929 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94207338 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62236730 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53875198 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51666299 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51666299 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51412047 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48786067 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47129389 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40064569 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38684276 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36154971 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29816870 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.22490169 |
| 18 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22016608 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18513018 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14562658 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10539702 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08580339 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02359664 |
| 24 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02031305 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97091521 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95796563 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90296456 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90001594 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83956286 |
| 30 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.83713278 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.79760029 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76245916 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66991332 |
| 34 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66627379 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.66550438 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60210791 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59590620 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58817558 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57081216 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52848351 |
| 41 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52068220 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51170010 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50296439 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49614233 |
| 45 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.47389580 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46672093 |
| 47 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46436066 |
| 48 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40385229 |
| 49 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38053133 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37322401 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35177952 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34181284 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33014632 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32869525 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32529863 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30411935 |
| 57 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28581186 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27435757 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26137518 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24361932 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23351989 |
| 62 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.22332314 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21895885 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20204901 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19005654 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18360245 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17394149 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16283336 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14677286 |
| 70 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13031362 |
| 71 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12192333 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11801415 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11774842 |
| 74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10930712 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10400725 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09879454 |
| 77 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08469420 |
| 78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08308466 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07706249 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05231684 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04062617 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03855727 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03145501 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02312414 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00955297 |
| 86 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00291457 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00067342 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99744166 |
| 89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99054728 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98536759 |
| 91 | * JUN_21703547_ChIP-Seq_K562_Human | 0.97902415 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96808781 |
| 93 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96771989 |
| 94 | AR_19668381_ChIP-Seq_PC3_Human | 0.96225248 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94506895 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93048593 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92614203 |
| 98 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92086212 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92016275 |
| 100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91432672 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91242104 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91099142 |
| 103 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90218411 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89779405 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89323370 |
| 106 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88510202 |
| 107 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88146961 |
| 108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87876329 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87650029 |
| 110 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87515328 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85846869 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85459190 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85293264 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84692443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.93868209 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.55116422 |
| 3 | MP0002822_catalepsy | 3.93809182 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.67759884 |
| 5 | MP0004270_analgesia | 3.45077826 |
| 6 | MP0009745_abnormal_behavioral_response | 3.39450529 |
| 7 | MP0002064_seizures | 3.18452441 |
| 8 | MP0009046_muscle_twitch | 3.13539678 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.99900321 |
| 10 | MP0001529_abnormal_vocalization | 2.95288793 |
| 11 | MP0002272_abnormal_nervous_system | 2.95043921 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.89321393 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.79357276 |
| 14 | MP0001486_abnormal_startle_reflex | 2.76684738 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.74653961 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.53726646 |
| 17 | MP0003329_amyloid_beta_deposits | 2.18659590 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.14791158 |
| 19 | MP0000920_abnormal_myelination | 2.13682134 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.12925026 |
| 21 | MP0002736_abnormal_nociception_after | 2.12572262 |
| 22 | MP0001970_abnormal_pain_threshold | 2.10999450 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.05894087 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.04520671 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.02927382 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.99066997 |
| 27 | MP0001905_abnormal_dopamine_level | 1.98537838 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.92343138 |
| 29 | MP0004924_abnormal_behavior | 1.92343138 |
| 30 | MP0000778_abnormal_nervous_system | 1.88702762 |
| 31 | MP0004142_abnormal_muscle_tone | 1.87887017 |
| 32 | MP0008569_lethality_at_weaning | 1.80139230 |
| 33 | MP0002184_abnormal_innervation | 1.66839270 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.62762496 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.60514635 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.56446281 |
| 37 | MP0004742_abnormal_vestibular_system | 1.55051844 |
| 38 | MP0004885_abnormal_endolymph | 1.54290088 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.48090752 |
| 40 | MP0000955_abnormal_spinal_cord | 1.45236488 |
| 41 | MP0003690_abnormal_glial_cell | 1.45015131 |
| 42 | MP0003633_abnormal_nervous_system | 1.43860101 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.42575666 |
| 44 | MP0001984_abnormal_olfaction | 1.41432180 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.36079843 |
| 46 | MP0005409_darkened_coat_color | 1.35434511 |
| 47 | MP0003631_nervous_system_phenotype | 1.31635530 |
| 48 | MP0002229_neurodegeneration | 1.30736024 |
| 49 | MP0001188_hyperpigmentation | 1.29131222 |
| 50 | MP0003634_abnormal_glial_cell | 1.26214182 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.22522580 |
| 52 | MP0003122_maternal_imprinting | 1.21639112 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.19780181 |
| 54 | MP0003879_abnormal_hair_cell | 1.19522184 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.18781551 |
| 56 | MP0005171_absent_coat_pigmentation | 1.17431653 |
| 57 | MP0004858_abnormal_nervous_system | 1.11865044 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.11788294 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.11647523 |
| 60 | MP0004147_increased_porphyrin_level | 1.11584847 |
| 61 | MP0003632_abnormal_nervous_system | 1.06996661 |
| 62 | MP0000604_amyloidosis | 1.06157352 |
| 63 | MP0004043_abnormal_pH_regulation | 1.05770674 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.04235036 |
| 65 | MP0001177_atelectasis | 1.02548697 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.01786426 |
| 67 | MP0003787_abnormal_imprinting | 1.01330542 |
| 68 | MP0002152_abnormal_brain_morphology | 1.00802103 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 0.98458394 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.97556279 |
| 71 | MP0008872_abnormal_physiological_respon | 0.96935186 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.95729508 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.92042741 |
| 74 | MP0008874_decreased_physiological_sensi | 0.89608778 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.88174728 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.86701103 |
| 77 | MP0000751_myopathy | 0.85788825 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.85282986 |
| 79 | MP0005410_abnormal_fertilization | 0.84201744 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.81070953 |
| 81 | MP0004085_abnormal_heartbeat | 0.80441181 |
| 82 | MP0005253_abnormal_eye_physiology | 0.77977926 |
| 83 | MP0003195_calcinosis | 0.77845715 |
| 84 | MP0002090_abnormal_vision | 0.76496659 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.74353248 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.73802441 |
| 87 | MP0005535_abnormal_body_temperature | 0.73281634 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.68547860 |
| 89 | MP0003121_genomic_imprinting | 0.67957039 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.66532644 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.65804308 |
| 92 | MP0001664_abnormal_digestion | 0.65145037 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.64389941 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.63895928 |
| 95 | MP0000566_synostosis | 0.62684661 |
| 96 | MP0001943_abnormal_respiration | 0.61988262 |
| 97 | MP0000026_abnormal_inner_ear | 0.61967566 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.60758963 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.60324509 |
| 100 | MP0005499_abnormal_olfactory_system | 0.59962516 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.59962516 |
| 102 | MP0003075_altered_response_to | 0.59649324 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.59264402 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.59047815 |
| 105 | MP0003136_yellow_coat_color | 0.58615341 |
| 106 | MP0008260_abnormal_autophagy | 0.56575712 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.56468873 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.54095451 |
| 109 | MP0000747_muscle_weakness | 0.53485371 |
| 110 | MP0004484_altered_response_of | 0.50186979 |
| 111 | MP0002082_postnatal_lethality | 0.49647192 |
| 112 | MP0010770_preweaning_lethality | 0.49647192 |
| 113 | MP0006072_abnormal_retinal_apoptosis | 0.49150837 |
| 114 | MP0005187_abnormal_penis_morphology | 0.48772671 |
| 115 | MP0010769_abnormal_survival | 0.48702422 |
| 116 | MP0003123_paternal_imprinting | 0.48625864 |
| 117 | MP0005195_abnormal_posterior_eye | 0.47933913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.96788965 |
| 2 | Myokymia (HP:0002411) | 6.18004359 |
| 3 | Focal seizures (HP:0007359) | 4.90621794 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.38853139 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.23011586 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.23011586 |
| 7 | Atonic seizures (HP:0010819) | 4.09717345 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.06962466 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 3.81356046 |
| 10 | Ankle clonus (HP:0011448) | 3.75657290 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.68031738 |
| 12 | Termporal pattern (HP:0011008) | 3.65306348 |
| 13 | Insidious onset (HP:0003587) | 3.65306348 |
| 14 | Febrile seizures (HP:0002373) | 3.62936053 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.57515565 |
| 16 | Visual hallucinations (HP:0002367) | 3.46848740 |
| 17 | Absence seizures (HP:0002121) | 3.45755050 |
| 18 | Dialeptic seizures (HP:0011146) | 3.44451136 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.43977012 |
| 20 | Broad-based gait (HP:0002136) | 3.42037980 |
| 21 | Action tremor (HP:0002345) | 3.39258069 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.26351119 |
| 23 | Limb dystonia (HP:0002451) | 3.21823660 |
| 24 | Spastic gait (HP:0002064) | 3.20044936 |
| 25 | Dysmetria (HP:0001310) | 3.17877307 |
| 26 | Hyperventilation (HP:0002883) | 3.15350350 |
| 27 | Hyperphosphatemia (HP:0002905) | 3.06213498 |
| 28 | Scanning speech (HP:0002168) | 2.99761993 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.88700893 |
| 30 | Pheochromocytoma (HP:0002666) | 2.83451722 |
| 31 | Poor eye contact (HP:0000817) | 2.82349584 |
| 32 | Tetany (HP:0001281) | 2.82247541 |
| 33 | Urinary urgency (HP:0000012) | 2.79097272 |
| 34 | Truncal ataxia (HP:0002078) | 2.79078914 |
| 35 | Peripheral hypomyelination (HP:0007182) | 2.77935117 |
| 36 | Anxiety (HP:0000739) | 2.77356286 |
| 37 | Increased circulating renin level (HP:0000848) | 2.75537054 |
| 38 | Onion bulb formation (HP:0003383) | 2.72906963 |
| 39 | Progressive inability to walk (HP:0002505) | 2.67513121 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.65623730 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.64468808 |
| 42 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.63706962 |
| 43 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.61732279 |
| 44 | Impaired social interactions (HP:0000735) | 2.60615762 |
| 45 | Abnormal social behavior (HP:0012433) | 2.60615762 |
| 46 | Torticollis (HP:0000473) | 2.58464083 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.56446703 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.51748055 |
| 49 | Status epilepticus (HP:0002133) | 2.51613456 |
| 50 | Intention tremor (HP:0002080) | 2.49694520 |
| 51 | Depression (HP:0000716) | 2.48573968 |
| 52 | Retinal dysplasia (HP:0007973) | 2.47419876 |
| 53 | Alacrima (HP:0000522) | 2.45411695 |
| 54 | Mutism (HP:0002300) | 2.44838465 |
| 55 | Sleep apnea (HP:0010535) | 2.43775765 |
| 56 | Lower limb muscle weakness (HP:0007340) | 2.40212294 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.38657566 |
| 58 | Dysmetric saccades (HP:0000641) | 2.37953518 |
| 59 | Split foot (HP:0001839) | 2.36979211 |
| 60 | Drooling (HP:0002307) | 2.36428573 |
| 61 | Excessive salivation (HP:0003781) | 2.36428573 |
| 62 | Focal dystonia (HP:0004373) | 2.32681498 |
| 63 | Polyphagia (HP:0002591) | 2.32616532 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.32301043 |
| 65 | Sensory axonal neuropathy (HP:0003390) | 2.27977573 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.26810448 |
| 67 | Hemiparesis (HP:0001269) | 2.26103466 |
| 68 | Craniofacial dystonia (HP:0012179) | 2.24731980 |
| 69 | Choreoathetosis (HP:0001266) | 2.24581066 |
| 70 | Diplopia (HP:0000651) | 2.24441828 |
| 71 | Abnormality of binocular vision (HP:0011514) | 2.24441828 |
| 72 | Hemiplegia (HP:0002301) | 2.22087619 |
| 73 | Leukodystrophy (HP:0002415) | 2.20761424 |
| 74 | Blue irides (HP:0000635) | 2.19589907 |
| 75 | Paraplegia (HP:0010550) | 2.17162120 |
| 76 | Gait imbalance (HP:0002141) | 2.15837624 |
| 77 | Decreased lacrimation (HP:0000633) | 2.14445474 |
| 78 | Clumsiness (HP:0002312) | 2.13782810 |
| 79 | Acute necrotizing encephalopathy (HP:0006965) | 2.11414634 |
| 80 | Generalized myoclonic seizures (HP:0002123) | 2.10966691 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10726859 |
| 82 | Postural instability (HP:0002172) | 2.08615805 |
| 83 | Spastic tetraparesis (HP:0001285) | 2.07923986 |
| 84 | Epileptiform EEG discharges (HP:0011182) | 2.07884379 |
| 85 | Clonus (HP:0002169) | 2.07832571 |
| 86 | Akinesia (HP:0002304) | 2.06102328 |
| 87 | Rigidity (HP:0002063) | 2.04520169 |
| 88 | Megalencephaly (HP:0001355) | 2.02886442 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02249665 |
| 90 | Stridor (HP:0010307) | 2.01491863 |
| 91 | Absent speech (HP:0001344) | 2.00011571 |
| 92 | Progressive macrocephaly (HP:0004481) | 1.97746714 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.97571038 |
| 94 | Specific learning disability (HP:0001328) | 1.96205163 |
| 95 | Resting tremor (HP:0002322) | 1.95476884 |
| 96 | Hypsarrhythmia (HP:0002521) | 1.95148582 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 1.95123667 |
| 98 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.95123667 |
| 99 | Aplasia of the phalanges of the hand (HP:0009802) | 1.95123667 |
| 100 | Amblyopia (HP:0000646) | 1.94831494 |
| 101 | Abnormal hair whorl (HP:0010721) | 1.94329980 |
| 102 | Papilledema (HP:0001085) | 1.94277831 |
| 103 | Psychosis (HP:0000709) | 1.92711664 |
| 104 | Postural tremor (HP:0002174) | 1.92052877 |
| 105 | Vaginal atresia (HP:0000148) | 1.91982274 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 1.91679138 |
| 107 | Parakeratosis (HP:0001036) | 1.90860403 |
| 108 | Thickened helices (HP:0000391) | 1.89433622 |
| 109 | Genital tract atresia (HP:0001827) | 1.89371020 |
| 110 | Abnormal auditory evoked potentials (HP:0006958) | 1.89016991 |
| 111 | Spastic tetraplegia (HP:0002510) | 1.88984906 |
| 112 | Inability to walk (HP:0002540) | 1.88893550 |
| 113 | Syncope (HP:0001279) | 1.87760820 |
| 114 | Slow saccadic eye movements (HP:0000514) | 1.87092576 |
| 115 | Stereotypic behavior (HP:0000733) | 1.86572454 |
| 116 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85428558 |
| 117 | Esotropia (HP:0000565) | 1.85287133 |
| 118 | Cerebral hypomyelination (HP:0006808) | 1.83908333 |
| 119 | Cerebral hemorrhage (HP:0001342) | 1.82692859 |
| 120 | Delusions (HP:0000746) | 1.82496218 |
| 121 | Fetal akinesia sequence (HP:0001989) | 1.82452501 |
| 122 | Bradykinesia (HP:0002067) | 1.82030692 |
| 123 | Gait ataxia (HP:0002066) | 1.81844453 |
| 124 | Bundle branch block (HP:0011710) | 1.80974546 |
| 125 | Autoamputation (HP:0001218) | 1.80865917 |
| 126 | Apathy (HP:0000741) | 1.80734058 |
| 127 | Rapidly progressive (HP:0003678) | 1.78646821 |
| 128 | Tetraplegia (HP:0002445) | 1.78051920 |
| 129 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74945101 |
| 130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.74541778 |
| 131 | Congenital primary aphakia (HP:0007707) | 1.74331283 |
| 132 | Congenital malformation of the right heart (HP:0011723) | 1.74003901 |
| 133 | Double outlet right ventricle (HP:0001719) | 1.74003901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.57467409 |
| 2 | NTRK3 | 3.38212922 |
| 3 | CASK | 3.27880871 |
| 4 | MARK1 | 2.93072928 |
| 5 | MAP3K9 | 2.64238158 |
| 6 | MAP3K4 | 2.54287746 |
| 7 | STK39 | 2.52456921 |
| 8 | MAP2K7 | 2.31207333 |
| 9 | OXSR1 | 2.30888350 |
| 10 | NTRK1 | 2.16579696 |
| 11 | PNCK | 2.09228653 |
| 12 | NTRK2 | 2.07070569 |
| 13 | MINK1 | 1.92898234 |
| 14 | DAPK2 | 1.85806523 |
| 15 | MAPKAPK5 | 1.80964659 |
| 16 | TNIK | 1.71779664 |
| 17 | CDK19 | 1.69355694 |
| 18 | UHMK1 | 1.68946657 |
| 19 | CAMKK2 | 1.61631471 |
| 20 | PAK6 | 1.59534570 |
| 21 | KSR2 | 1.55132560 |
| 22 | MAPK13 | 1.54379578 |
| 23 | CDK5 | 1.46378852 |
| 24 | MAP4K2 | 1.41218432 |
| 25 | SGK494 | 1.40603299 |
| 26 | SGK223 | 1.40603299 |
| 27 | ARAF | 1.40315538 |
| 28 | MAP2K4 | 1.40153953 |
| 29 | PKN1 | 1.40002209 |
| 30 | MAP3K12 | 1.37164008 |
| 31 | CAMK2B | 1.34056305 |
| 32 | BCR | 1.33062411 |
| 33 | RIPK4 | 1.29411774 |
| 34 | GRK5 | 1.26643318 |
| 35 | MUSK | 1.23887342 |
| 36 | CAMK2A | 1.18274605 |
| 37 | FGFR2 | 1.17226473 |
| 38 | CAMKK1 | 1.14598328 |
| 39 | PLK2 | 1.13229905 |
| 40 | FES | 1.12284971 |
| 41 | WNK4 | 1.10527278 |
| 42 | KSR1 | 1.06152894 |
| 43 | WNK1 | 1.05840012 |
| 44 | CSNK1G2 | 1.03898503 |
| 45 | GRK7 | 1.02785461 |
| 46 | PRPF4B | 1.00549536 |
| 47 | PHKG1 | 0.99687132 |
| 48 | PHKG2 | 0.99687132 |
| 49 | FRK | 0.98037460 |
| 50 | SIK2 | 0.97422908 |
| 51 | PRKD3 | 0.97389852 |
| 52 | CAMK2D | 0.93137440 |
| 53 | CDK14 | 0.91968677 |
| 54 | EPHB1 | 0.90561795 |
| 55 | CDK18 | 0.89223582 |
| 56 | PRKCE | 0.89219377 |
| 57 | PRKCG | 0.89186268 |
| 58 | MAP3K2 | 0.87818982 |
| 59 | CDK15 | 0.87347849 |
| 60 | ERBB3 | 0.85375934 |
| 61 | CSNK1G3 | 0.84935363 |
| 62 | NEK6 | 0.83032896 |
| 63 | ROCK2 | 0.81122095 |
| 64 | MARK2 | 0.80690739 |
| 65 | BMPR2 | 0.80170917 |
| 66 | CAMK2G | 0.78875478 |
| 67 | FGR | 0.76864783 |
| 68 | TYRO3 | 0.76670766 |
| 69 | LIMK1 | 0.75246512 |
| 70 | CDK11A | 0.74746905 |
| 71 | TESK1 | 0.74556039 |
| 72 | PAK3 | 0.73013328 |
| 73 | MAP3K13 | 0.72886862 |
| 74 | CAMK1G | 0.71315516 |
| 75 | ADRBK2 | 0.69579067 |
| 76 | DYRK2 | 0.67400325 |
| 77 | STK11 | 0.67084210 |
| 78 | CAMK1 | 0.64892620 |
| 79 | CSNK1A1L | 0.64566069 |
| 80 | DAPK1 | 0.63814710 |
| 81 | DYRK1A | 0.63636886 |
| 82 | STK38 | 0.63178058 |
| 83 | SGK1 | 0.62384335 |
| 84 | MAPK10 | 0.61262391 |
| 85 | PINK1 | 0.57464403 |
| 86 | PDK2 | 0.55193106 |
| 87 | AKT3 | 0.54661572 |
| 88 | CSNK1D | 0.54431551 |
| 89 | NME1 | 0.54036625 |
| 90 | PRKCH | 0.53799608 |
| 91 | LATS2 | 0.53503239 |
| 92 | FYN | 0.51357923 |
| 93 | PDPK1 | 0.50777855 |
| 94 | CSNK1G1 | 0.49648523 |
| 95 | PTK2B | 0.49611566 |
| 96 | EPHA3 | 0.48427239 |
| 97 | ALK | 0.48102069 |
| 98 | PRKCA | 0.47780326 |
| 99 | ADRBK1 | 0.47049038 |
| 100 | SGK2 | 0.46356452 |
| 101 | TNK2 | 0.45886446 |
| 102 | CSNK1A1 | 0.45267993 |
| 103 | CAMK4 | 0.44984535 |
| 104 | WNK3 | 0.44771308 |
| 105 | DAPK3 | 0.44724110 |
| 106 | PRKACA | 0.44491154 |
| 107 | CSNK1E | 0.44489291 |
| 108 | RET | 0.44340445 |
| 109 | PRKG1 | 0.42297163 |
| 110 | PRKCZ | 0.42119817 |
| 111 | RAF1 | 0.41271912 |
| 112 | SGK3 | 0.41003030 |
| 113 | PRKD1 | 0.40560762 |
| 114 | MAP3K6 | 0.40461991 |
| 115 | PDK1 | 0.39350703 |
| 116 | MAPK12 | 0.39045745 |
| 117 | RPS6KA3 | 0.39045177 |
| 118 | FER | 0.38685420 |
| 119 | ERBB4 | 0.38353596 |
| 120 | PRKCB | 0.34693490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53819058 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98806494 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.91618389 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71149343 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.63271781 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50408451 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47942871 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35891710 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16259368 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.10027924 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08791370 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.04702624 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.03603829 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.00397192 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.99364370 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97550040 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.85811248 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.81226308 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80975361 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.73381952 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69049619 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65601394 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61164680 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.60467408 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55142209 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.49797936 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40840167 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.40723933 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39700796 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36289966 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35925533 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.30242254 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30235840 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30212147 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29017668 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28809783 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.27761998 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26759136 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.24474746 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.17817963 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16058595 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13939801 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06173584 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03132079 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00407311 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00195826 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00016988 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99848609 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93507437 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91984763 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89523129 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89508973 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87639229 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 0.86247706 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84551725 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83154693 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82931518 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82651592 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82421910 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81794367 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81653540 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79208186 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77278792 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.77195423 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76676805 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.73338085 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73149667 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72830563 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71912213 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71085773 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70944769 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70853094 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69998195 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68133825 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63795242 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63516377 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62839590 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.61534904 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61295967 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61157849 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60905184 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60423238 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59838047 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59483020 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58865986 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57073720 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56654006 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.55564077 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55238232 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53923454 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51950937 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51882714 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49159278 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48507459 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47687800 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46421891 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46249109 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.43604476 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42963012 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42895787 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42036626 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41864112 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.40991007 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.40686723 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39688628 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39090724 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.38882236 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.37786873 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37689245 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37530141 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36628947 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35711437 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35672346 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34612802 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32742943 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30216397 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23362455 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22493947 |

